Legal Representation
Attorney
Colleen Ganin
USPTO Deadlines
Next Deadline
687 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-01)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 28, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 28, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Feb 28, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 28, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 1, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 28, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 27, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 21, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 21, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 21, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 7, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 7, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 7, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 7, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 22, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 18, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 18, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 18, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 31, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 31, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 31, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 24, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 22, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 22, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 23, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 1, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 1, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 1, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 1, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 1, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 26, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 9, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 7, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Providing medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment
First Use Anywhere:
Dec 5, 2020
First Use in Commerce:
Dec 5, 2020
Additional Information
Design Mark
The mark consists of the words "ALLOGENE THERAPEUTICS" next to a dotted circle design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"